Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 169

1.

Dynamic predictions of long-term kidney graft failure: an information tool promoting patient-centred care.

Fournier MC, Foucher Y, Blanche P, Legendre C, Girerd S, Ladrière M, Morelon E, Buron F, Rostaing L, Kamar N, Mourad G, Garrigue V, Couvrat-Desvergnes G, Giral M, Dantan E; DIVAT Consortium.

Nephrol Dial Transplant. 2019 Mar 11. pii: gfz027. doi: 10.1093/ndt/gfz027. [Epub ahead of print]

PMID:
30859193
2.

Early Acute Microvascular Kidney Transplant Rejection in the Absence of Anti-HLA Antibodies Is Associated with Preformed IgG Antibodies against Diverse Glomerular Endothelial Cell Antigens.

Delville M, Lamarthée B, Pagie S, See SB, Rabant M, Burger C, Gatault P, Giral M, Thaunat O, Arzouk N, Hertig A, Hazzan M, Matignon M, Mariat C, Caillard S, Kamar N, Sayegh J, Westeel PF, Garrouste C, Ladrière M, Vuiblet V, Rivalan J, Merville P, Bertrand D, Le Moine A, Van Huyen JPD, Cesbron A, Cagnard N, Alibeu O, Satchell SC, Legendre C, Zorn E, Taupin JL, Charreau B, Anglicheau D.

J Am Soc Nephrol. 2019 Apr;30(4):692-709. doi: 10.1681/ASN.2018080868. Epub 2019 Mar 8.

PMID:
30850439
3.

Lack of impact of pre-emptive deceased-donor kidney transplantation on graft outcomes: a propensity score-based study.

Foucher Y, Le Borgne F, Legendre C, Morelon E, Buron F, Girerd S, Ladrière M, Mourad G, Garrigue V, Glotz D, Lefaucheur C, Cassuto E, Albano L, Giral M.

Nephrol Dial Transplant. 2019 May 1;34(5):886-891. doi: 10.1093/ndt/gfy317.

PMID:
30325453
4.

Comparison of graft and patient survival according to the transplantation centre policy for 1-year screening biopsy among stable kidney recipients: a propensity score-based study.

Couvrat-Desvergnes G, Foucher Y, Le Borgne F, Dion A, Mourad G, Garrigue V, Legendre C, Rostaing L, Kamar N, Kessler M, Ladrière M, Morelon E, Buron F, Giral M, Dantan E.

Nephrol Dial Transplant. 2019 Apr 1;34(4):703-711. doi: 10.1093/ndt/gfy221.

PMID:
30060106
5.

Analyses of the short- and long-term graft survival after kidney transplantation in Europe between 1986 and 2015.

Coemans M, Süsal C, Döhler B, Anglicheau D, Giral M, Bestard O, Legendre C, Emonds MP, Kuypers D, Molenberghs G, Verbeke G, Naesens M.

Kidney Int. 2018 Nov;94(5):964-973. doi: 10.1016/j.kint.2018.05.018. Epub 2018 Jul 24.

PMID:
30049474
6.

The 1-year Renal Biopsy Index: a scoring system to drive biopsy indication at 1-year post-kidney transplantation.

Giral M, Renaudin K, Naesens M, Luning R, Anglicheau D, Morelon E, Huneau A, Paul C, Brouard S, Couvrat-Desvergnes G, Foucher Y, Dantan E.

Transpl Int. 2018 Jun 12. doi: 10.1111/tri.13290. [Epub ahead of print] Review.

7.

HCMV triggers frequent and persistent UL40-specific unconventional HLA-E-restricted CD8 T-cell responses with potential autologous and allogeneic peptide recognition.

Jouand N, Bressollette-Bodin C, Gérard N, Giral M, Guérif P, Rodallec A, Oger R, Parrot T, Allard M, Cesbron-Gautier A, Gervois N, Charreau B.

PLoS Pathog. 2018 Apr 30;14(4):e1007041. doi: 10.1371/journal.ppat.1007041. eCollection 2018 Apr.

8.

Poor Patient and Graft Outcome After Induction Treatment by Antithymocyte Globulin in Recipients of a Kidney Graft After Nonrenal Organ Transplantation.

Mai HL, Treilhaud M, Ben-Arye SL, Yu H, Perreault H, Ang E, Trébern-Launay K, Laurent J, Malard-Castagnet S, Cesbron A, Nguyen TVH, Brouard S, Rostaing L, Houssel-Debry P, Legendre C, Girerd S, Kessler M, Morelon E, Sicard A, Garrigue V, Karam G, Chen X, Giral M, Padler-Karavani V, Soulillou JP.

Transplant Direct. 2018 Mar 20;4(4):e357. doi: 10.1097/TXD.0000000000000772. eCollection 2018 Apr.

9.

Corrigendum: Broad Impairment of Natural Killer Cells From Operationally Tolerant Kidney Transplanted Patients.

Dugast E, David G, Oger R, Danger R, Judor JP, Gagne K, Chesneau M, Degauque N, Soulillou JP, Paul P, Picard C, Guerif P, Conchon S, Giral M, Gervois N, Retière C, Brouard S.

Front Immunol. 2018 Mar 26;9:589. doi: 10.3389/fimmu.2018.00589. eCollection 2018.

10.

Candida utilis fungaemia following endoscopic intervention on ureteral stent in a kidney transplant recipient: Case report and a review of the literature.

Gaisne R, Jeddi F, Morio F, Le Clerc QC, Hourmant M, Blancho G, Giral M, Cantarovich D, Dantal J, Ville S.

Mycoses. 2018 Aug;61(8):594-599. doi: 10.1111/myc.12766. Epub 2018 Jun 11. Review.

PMID:
29575315
11.

Increased degradation of ATP is driven by memory regulatory T cells in kidney transplantation tolerance.

Durand M, Dubois F, Dejou C, Durand E, Danger R, Chesneau M, Brosseau C, Guerif P, Soulillou JP, Degauque N, Eliaou JF, Giral M, Bonnefoy N, Brouard S.

Kidney Int. 2018 May;93(5):1154-1164. doi: 10.1016/j.kint.2017.12.004. Epub 2018 Feb 15.

PMID:
29455908
12.

Health care and societal costs of the management of children and adolescents with attention-deficit/hyperactivity disorder in Spain: a descriptive analysis.

Quintero J, Ramos-Quiroga JA, Sebastián JS, Montañés F, Fernández-Jaén A, Martínez-Raga J, Giral MG, Graell M, Mardomingo MJ, Soutullo C, Eiris J, Téllez M, Pamias M, Correas J, Sabaté J, García-Orti L, Alda JA.

BMC Psychiatry. 2018 Feb 8;18(1):40. doi: 10.1186/s12888-017-1581-y.

13.

Propensity score-based comparison of the graft failure risk between kidney transplant recipients of standard and expanded criteria donor grafts: Toward increasing the pool of marginal donors.

Querard AH, Le Borgne F, Dion A, Giral M, Mourad G, Garrigue V, Rostaing L, Kamar N, Loupy A, Legendre C, Morelon E, Buron F, Foucher Y, Dantan E.

Am J Transplant. 2018 May;18(5):1151-1157. doi: 10.1111/ajt.14651. Epub 2018 Feb 8.

14.

Broad Impairment of Natural Killer Cells from Operationally Tolerant Kidney Transplanted Patients.

Dugast E, David G, Oger R, Danger R, Judor JP, Gagne K, Chesneau M, Degauque N, Soulillou JP, Paul P, Picard C, Guerif P, Conchon S, Giral M, Gervois N, Retière C, Brouard S.

Front Immunol. 2017 Dec 11;8:1721. doi: 10.3389/fimmu.2017.01721. eCollection 2017. Erratum in: Front Immunol. 2018 Mar 26;9:589.

15.

Preemptive second kidney transplantation is associated with better graft survival compared with non-preemptive second transplantation: a multicenter French 2000-2014 cohort study.

Girerd S, Girerd N, Duarte K, Giral M, Legendre C, Mourad G, Garrigue V, Morelon E, Buron F, Kamar N, Del Bello A, Ladrière M, Kessler M, Frimat L.

Transpl Int. 2018 Apr;31(4):408-423. doi: 10.1111/tri.13105. Epub 2017 Dec 20.

16.

Horizontal mixture model for competing risks: a method used in waitlisted renal transplant candidates.

Trébern-Launay K, Kessler M, Bayat-Makoei S, Quérard AH, Briançon S, Giral M, Foucher Y.

Eur J Epidemiol. 2018 Mar;33(3):275-286. doi: 10.1007/s10654-017-0322-3. Epub 2017 Oct 30.

PMID:
29086099
17.

Impact of antiviral prophylaxis in adults Epstein-Barr Virus-seronegative kidney recipients on early and late post-transplantation lymphoproliferative disorder onset: a retrospective cohort study.

Ville S, Imbert-Marcille BM, Coste-Burel M, Garandeau C, Meurette A, Cantarovitch D, Giral M, Hourmant M, Blancho G, Dantal J.

Transpl Int. 2018 May;31(5):484-494. doi: 10.1111/tri.13085. Epub 2018 Jan 16.

18.

Optimal threshold estimator of a prognostic marker by maximizing a time-dependent expected utility function for a patient-centered stratified medicine.

Dantan E, Foucher Y, Lorent M, Giral M, Tessier P.

Stat Methods Med Res. 2018 Jun;27(6):1847-1859. doi: 10.1177/0962280216671161. Epub 2016 Oct 20.

PMID:
28937334
19.

Looking at hospitalized persons throughout the prism of the handicap.

Giral M, Boussat B, Lombard F, Stempfle S, François P, Pérennou D.

Ann Phys Rehabil Med. 2018 Jan;61(1):12-17. doi: 10.1016/j.rehab.2017.03.001. Epub 2017 Jul 14.

20.

IL-15 Harnesses Pro-inflammatory Function of TEMRA CD8 in Kidney-Transplant Recipients.

Tilly G, Doan-Ngoc TM, Yap M, Caristan A, Jacquemont L, Danger R, Cadoux M, Bruneau S, Giral M, Guerif P, Nicol B, Garcia A, Laplaud DA, Brouard S, Pecqueur Hellman C, Degauque N.

Front Immunol. 2017 Jun 30;8:778. doi: 10.3389/fimmu.2017.00778. eCollection 2017.

21.

Is pre-transplant sensitization against angiotensin II type 1 receptor still a risk factor of graft and patient outcome in kidney transplantation in the anti-HLA Luminex era? A retrospective study.

Deltombe C, Gillaizeau F, Anglicheau D, Morelon E, Trébern-Launay K, Le Borgne F, Rimbert M, Guérif P, Malard-Castagnet S, Foucher Y, Giral M.

Transpl Int. 2017 Nov;30(11):1150-1160. doi: 10.1111/tri.13009. Epub 2017 Oct 5.

22.

Standardized and weighted time-dependent receiver operating characteristic curves to evaluate the intrinsic prognostic capacities of a marker by taking into account confounding factors.

Le Borgne F, Combescure C, Gillaizeau F, Giral M, Chapal M, Giraudeau B, Foucher Y.

Stat Methods Med Res. 2018 Nov;27(11):3397-3410. doi: 10.1177/0962280217702416. Epub 2017 Jun 20.

PMID:
28633603
23.

A composite score associated with spontaneous operational tolerance in kidney transplant recipients.

Danger R, Chesneau M, Paul C, Guérif P, Durand M, Newell KA, Kanaparthi S, Turka LA, Soulillou JP, Houlgatte R, Giral M, Ramstein G, Brouard S.

Kidney Int. 2017 Jun;91(6):1473-1481. doi: 10.1016/j.kint.2016.12.020. Epub 2017 Feb 24.

24.

Renal Operational Tolerance Is Associated With a Defect of Blood Tfh Cells That Exhibit Impaired B Cell Help.

Chenouard A, Chesneau M, Bui Nguyen L, Le Bot S, Cadoux M, Dugast E, Paul C, Malard-Castagnet S, Ville S, Guérif P, Soulillou JP, Degauque N, Danger R, Giral M, Brouard S.

Am J Transplant. 2017 Jun;17(6):1490-1501. doi: 10.1111/ajt.14142. Epub 2017 Jan 19.

25.

Failure of Calcineurin Inhibitor (Tacrolimus) Weaning Randomized Trial in Long-Term Stable Kidney Transplant Recipients.

Dugast E, Soulillou JP, Foucher Y, Papuchon E, Guerif P, Paul C, Riochet D, Chesneau M, Cesbron A, Renaudin K, Dantal J, Giral M, Brouard S.

Am J Transplant. 2016 Nov;16(11):3255-3261. doi: 10.1111/ajt.13946. Epub 2016 Jul 29.

26.

Mortality Prediction after the First Year of Kidney Transplantation: An Observational Study on Two European Cohorts.

Lorent M, Giral M, Pascual M, Koller MT, Steiger J, Trébern-Launay K, Legendre C, Kreis H, Mourad G, Garrigue V, Rostaing L, Kamar N, Kessler M, Ladrière M, Morelon E, Buron F, Golshayan D, Foucher Y.

PLoS One. 2016 May 6;11(5):e0155278. doi: 10.1371/journal.pone.0155278. eCollection 2016.

27.

A joint model for longitudinal and time-to-event data to better assess the specific role of donor and recipient factors on long-term kidney transplantation outcomes.

Fournier MC, Foucher Y, Blanche P, Buron F, Giral M, Dantan E.

Eur J Epidemiol. 2016 May;31(5):469-79. doi: 10.1007/s10654-016-0121-2. Epub 2016 Feb 1.

PMID:
26832337
28.

Benefits of Using CD45RA and CD28 to Investigate CD8 Subsets in Kidney Transplant Recipients.

Yap M, Tilly G, Giral M, Brouard S, Degauque N.

Am J Transplant. 2016 Mar;16(3):999-1006. doi: 10.1111/ajt.13581. Epub 2016 Jan 28.

29.

Prospective, multicenter, controlled study of quality of life, psychological adjustment process and medical outcomes of patients receiving a preemptive kidney transplant compared to a similar population of recipients after a dialysis period of less than three years--The PreKit-QoL study protocol.

Sébille V, Hardouin JB, Giral M, Bonnaud-Antignac A, Tessier P, Papuchon E, Jobert A, Faurel-Paul E, Gentile S, Cassuto E, Morélon E, Rostaing L, Glotz D, Sberro-Soussan R, Foucher Y, Meurette A.

BMC Nephrol. 2016 Jan 19;17:11. doi: 10.1186/s12882-016-0225-7.

30.

The DESCARTES-Nantes survey of kidney transplant recipients displaying clinical operational tolerance identifies 35 new tolerant patients and 34 almost tolerant patients.

Massart A, Pallier A, Pascual J, Viklicky O, Budde K, Spasovski G, Klinger M, Sever MS, Sørensen SS, Hadaya K, Oberbauer R, Dudley C, De Fijter JW, Yussim A, Hazzan M, Wekerle T, Berglund D, De Biase C, Pérez-Sáez MJ, Mühlfeld A, Orlando G, Clemente K, Lai Q, Pisani F, Kandus A, Baas M, Bemelman F, Ponikvar JB, Mazouz H, Stratta P, Subra JF, Villemain F, Hoitsma A, Braun L, Cantarell MC, Colak H, Courtney A, Frasca GM, Howse M, Naesens M, Reischig T, Serón D, Seyahi N, Tugmen C, Alonso Hernandez A, Beňa L, Biancone L, Cuna V, Díaz-Corte C, Dufay A, Gaasbeek A, Garnier A, Gatault P, Gentil Govantes MA, Glowacki F, Gross O, Hurault de Ligny B, Huynh-Do U, Janbon B, Jiménez Del Cerro LA, Keller F, La Manna G, Lauzurica R, Le Monies De Sagazan H, Thaiss F, Legendre C, Martin S, Moal MC, Noël C, Pillebout E, Piredda GB, Puga AR, Sulowicz W, Tuglular S, Prokopova M, Chesneau M, Le Moine A, Guérif P, Soulillou JP, Abramowicz M, Giral M, Racapé J, Maggiore U, Brouard S, Abramowicz D.

Nephrol Dial Transplant. 2016 Jun;31(6):1002-13. doi: 10.1093/ndt/gfv437. Epub 2016 Jan 12.

PMID:
26763669
31.

Comparison of survival outcomes between Expanded Criteria Donor and Standard Criteria Donor kidney transplant recipients: a systematic review and meta-analysis.

Querard AH, Foucher Y, Combescure C, Dantan E, Larmet D, Lorent M, Pouteau LM, Giral M, Gillaizeau F.

Transpl Int. 2016 Apr;29(4):403-15. doi: 10.1111/tri.12736. Epub 2016 Feb 12. Review.

32.

Rabbit antithymocyte globulin-induced serum sickness disease and human kidney graft survival.

Couvrat-Desvergnes G, Salama A, Le Berre L, Evanno G, Viklicky O, Hruba P, Vesely P, Guerif P, Dejoie T, Rousse J, Nicot A, Bach JM, Ang E, Foucher Y, Brouard S, Castagnet S, Giral M, Harb J, Perreault H, Charreau B, Lorent M, Soulillou JP.

J Clin Invest. 2015 Dec;125(12):4655-65. doi: 10.1172/JCI82267. Epub 2015 Nov 9.

33.

Sialylation of antibodies in kidney recipients with de novo donor specific antibody, with or without antibody mediated rejection.

Malard-Castagnet S, Dugast E, Degauque N, Pallier A, Soulillou JP, Cesbron A, Giral M, Harb J, Brouard S.

Hum Immunol. 2016 Nov;77(11):1076-1083. doi: 10.1016/j.humimm.2015.10.021. Epub 2015 Nov 10.

PMID:
26546874
34.

Comparisons of the performance of different statistical tests for time-to-event analysis with confounding factors: practical illustrations in kidney transplantation.

Le Borgne F, Giraudeau B, Querard AH, Giral M, Foucher Y.

Stat Med. 2016 Mar 30;35(7):1103-16. doi: 10.1002/sim.6777. Epub 2015 Oct 29.

PMID:
26514380
35.

Vitamin D deficiency is an independent risk factor for PTDM after kidney transplantation.

Le Fur A, Fournier MC, Gillaizeau F, Masson D, Giral M, Cariou B, Cantarovich D, Dantal J.

Transpl Int. 2016 Feb;29(2):207-15. doi: 10.1111/tri.12697. Epub 2015 Oct 29.

36.

Long term outcomes of transplantation using kidneys from expanded criteria donors: prospective, population based cohort study.

Aubert O, Kamar N, Vernerey D, Viglietti D, Martinez F, Duong-Van-Huyen JP, Eladari D, Empana JP, Rabant M, Verine J, Rostaing L, Congy N, Guilbeau-Frugier C, Mourad G, Garrigue V, Morelon E, Giral M, Kessler M, Ladrière M, Delahousse M, Glotz D, Legendre C, Jouven X, Lefaucheur C, Loupy A.

BMJ. 2015 Jul 31;351:h3557. doi: 10.1136/bmj.h3557.

37.

Excellent long-term outcome of renal transplantation in cystinosis patients.

Cohen C, Charbit M, Chadefaux-Vekemans B, Giral M, Garrigue V, Kessler M, Antoine C, Snanoudj R, Niaudet P, Kreis H, Legendre C, Servais A.

Orphanet J Rare Dis. 2015 Jul 25;10:90. doi: 10.1186/s13023-015-0307-9.

38.

Peripheral phenotype and gene expression profiles of combined liver-kidney transplant patients.

Dumontet E, Danger R, Vagefi PA, Londoño MC, Pallier A, Lozano JJ, Giral M, Degauque N, Soulillou JP, Martínez-Llordella M, Lee H, Latournerie M, Boudjema K, Dulong J, Tarte K, Sanchez-Fueyo A, Feng S, Brouard S, Conchon S.

Liver Int. 2016 Mar;36(3):401-9. doi: 10.1111/liv.12917. Epub 2015 Aug 8.

39.

PREventing Delayed Graft Function by Driving Immunosuppressive InduCtion Treatment (PREDICT-DGF): study protocol for a randomized controlled trial.

Chapal M, Foucher Y, Marguerite M, Neau K, Papuchon E, Daguin P, Morélon E, Mourad G, Cassuto E, Ladrière M, Legendre C, Giral M.

Trials. 2015 Jun 23;16:282. doi: 10.1186/s13063-015-0807-x.

40.

A multistate additive relative survival semi-Markov model.

Gillaizeau F, Dantan E, Giral M, Foucher Y.

Stat Methods Med Res. 2017 Aug;26(4):1700-1711. doi: 10.1177/0962280215586456. Epub 2015 Jun 7.

PMID:
26056059
41.

Effects of Changing to Individually Ventilated Caging on Guinea Pigs (Cavia porcellus).

Giral M, Armengol C, Sánchez-Gómez S, Gavaldà A.

J Am Assoc Lab Anim Sci. 2015 May;54(3):267-72.

42.

Reconsidering the detection of tolerance to individualize immunosuppression minimization and to improve long-term kidney graft outcomes.

Baron D, Giral M, Brouard S.

Transpl Int. 2015 Aug;28(8):938-59. doi: 10.1111/tri.12578. Epub 2015 Apr 21. Review.

43.

Tolerant Kidney Transplant Patients Produce B Cells with Regulatory Properties.

Chesneau M, Michel L, Dugast E, Chenouard A, Baron D, Pallier A, Durand J, Braza F, Guerif P, Laplaud DA, Soulillou JP, Giral M, Degauque N, Chiffoleau E, Brouard S.

J Am Soc Nephrol. 2015 Oct;26(10):2588-98. doi: 10.1681/ASN.2014040404. Epub 2015 Feb 2.

44.

A personalized follow-up of kidney transplant recipients using video conferencing based on a 1-year scoring system predictive of long term graft failure (TELEGRAFT study): protocol for a randomized controlled trial.

Foucher Y, Meurette A, Daguin P, Bonnaud-Antignac A, Hardouin JB, Chailan S, Neau K, Papuchon E, Gaboriau S, Legendre C, Morélon E, Tessier P, Giral M.

BMC Nephrol. 2015 Jan 28;16:6. doi: 10.1186/1471-2369-16-6.

45.

A common gene signature across multiple studies relate biomarkers and functional regulation in tolerance to renal allograft.

Baron D, Ramstein G, Chesneau M, Echasseriau Y, Pallier A, Paul C, Degauque N, Hernandez-Fuentes MP, Sanchez-Fueyo A, Newell KA, Giral M, Soulillou JP, Houlgatte R, Brouard S.

Kidney Int. 2015 May;87(5):984-95. doi: 10.1038/ki.2014.395. Epub 2015 Jan 28.

46.

Central Role of CD45RA- Foxp3hi Memory Regulatory T Cells in Clinical Kidney Transplantation Tolerance.

Braza F, Dugast E, Panov I, Paul C, Vogt K, Pallier A, Chesneau M, Baron D, Guerif P, Lei H, Laplaud DA, Volk HD, Degauque N, Giral M, Soulillou JP, Sawitzki B, Brouard S.

J Am Soc Nephrol. 2015 Aug;26(8):1795-805. doi: 10.1681/ASN.2014050480. Epub 2015 Jan 2.

47.

Early and irreversible recurrence MPO-ANCA-positive glomerulonephritis after renal transplantation.

Le Berre L, Dufay A, Cantarovich D, Meurette A, Audrain M, Giral M, Blancho G, Fakhouri F, Hourmant M, Dantal J.

Clin Nephrol. 2015 Jun;83(6):357-62. doi: 10.5414/CN108303.

PMID:
25345380
48.

Disseminated Mucormycosis With Cerebral Involvement Owing to Rhizopus Microsporus in a Kidney Recipient Treated With Combined Liposomal Amphotericin B and Posaconazole Therapy.

Ville S, Talarmin JP, Gaultier-Lintia A, Bouquié R, Sagan C, Le Pape P, Giral M, Morio F.

Exp Clin Transplant. 2016 Feb;14(1):96-9. doi: 10.6002/ect.2014.0093. Epub 2014 Sep 30.

49.

Each additional hour of cold ischemia time significantly increases the risk of graft failure and mortality following renal transplantation.

Debout A, Foucher Y, Trébern-Launay K, Legendre C, Kreis H, Mourad G, Garrigue V, Morelon E, Buron F, Rostaing L, Kamar N, Kessler M, Ladrière M, Poignas A, Blidi A, Soulillou JP, Giral M, Dantan E.

Kidney Int. 2015 Feb;87(2):343-9. doi: 10.1038/ki.2014.304. Epub 2014 Sep 17.

PMID:
25229341
50.

Differential modulation of donor-specific antibodies after B-cell depleting therapies to cure chronic antibody mediated rejection.

Touzot M, Couvrat-Desvergnes G, Castagnet S, Cesbron A, Renaudin K, Cantarovich D, Giral M.

Transplantation. 2015 Jan;99(1):63-8. doi: 10.1097/TP.0000000000000285.

PMID:
25029384

Supplemental Content

Support Center